Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · SCHEDULE 13G/A

Waters Corp

WATNYSEEQUITYCurrent

SEC Filing

Filed May 15, 2026Accepted May 15, 2026, 6:53 AM EDTCIK 1000697Accession 0001569205-26-000007
Share

Company context

Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide.

Current securities

Recent company filings

  1. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsAug 21, 2026
  2. 10-Q filingAug 11, 2026
  3. 144 filingAug 6, 2026
  4. Results of Operations and Financial ConditionAug 4, 2026
  5. 4 filingJul 2, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗